Jarkko Rautio is Professor in Pharmaceutical Chemistry and a deputy head at the School of Pharmacy, University of Eastern Finland (UEF). His research focuses on the chemistry-based methods, especially prodrugs, to overcome drug delivery liabilities of problematic drugs. He has published over 50 papers and book chapters on prodrugs. Much of his research is currently focusing on exploiting one of the body’s natural mechanisms for transporting amino acids, the LAT1 protein, for targeted drug delivery across the blood-brain barrier (BBB) and cancer cells that express this transporter.
Professor Rautio co-founded the American Association of Pharmaceutical Scientists (AAPS) Prodrug Focus Group in 2005.